Journal ArticleDOI
Multinational comparative clinical trial of long-acting injectable contraceptives: Norethisterone enanthate given in two dosage regimens and depot-medroxyprogesterone acetate. Final report. Who special programme of research, development and research training in human reproduction
H.K. Toppozada,Suporn Koetsawang,V. E. Aimakhu,T. Khan,A. Pretnar-Darovec,T.K. Chatterjee,M. P. Molitor-Peffer,R. Apelo,R. Lichtenberg,P. G. Crosignani,J.C. de Souza,M. Garcia Huidubro,A.A. Haspels,J. Annus,G. Benaginao,P. Diethelm,R. Gray,P.E. Hall,S. Holck +18 more
Reads0
Chats0
TLDR
All three injectable regimens compare favourably with oral contraceptives in terms of pregnancy and total continuation rates observed in clinical trial settings and for family planning programs, NET-EN (60-day) has the advantage of low pregnancy rates compared to NET- EN (84-day), and a schedule of administration that does not change.About:
This article is published in Contraception.The article was published on 1983-07-01. It has received 92 citations till now. The article focuses on the topics: Norethisterone enanthate & Regimen.read more
Citations
More filters
Journal ArticleDOI
Contraceptive failure in the United States
TL;DR: This review provides an update of previous estimates of first-year probabilities of contraceptive failure for all methods of contraception available in the United States and reflects new research on contraceptive failure both during perfect use and during typical use.
Journal ArticleDOI
Strategies to prevent unintended pregnancy: increasing use of long-acting reversible contraception
TL;DR: The role of LARC methods and importance of contraceptive counseling in reducing unintended pregnancy rates are discussed, as women who receive counseling before use demonstrate higher rates of after-use method satisfaction, continuation and acceptance than those who do not.
Journal ArticleDOI
Effect of counseling to improve compliance in Mexican women receiving depot-medroxyprogesterone acetate
TL;DR: In this paper, the effect of pretreatment counseling upon discontinuation of 150 mg depot-medroxyprogesterone acetate (Depo-Provera) given for contraception was evaluated.
Journal ArticleDOI
The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guideline.
TL;DR: Assessment of the cost-effectiveness of long-acting reversible contraceptive methods from the British National Health Service perspective concluded that practices improving user satisfaction and continuation of LARC method use should be identified and promoted.
Original research article Effect of counseling to improve compliance in Mexican women receiving depot-medroxyprogesterone acetate
TL;DR: The findings suggest that pretreatment counseling on expected side effects increases the continuation rates of DMPA users.
References
More filters
Journal ArticleDOI
Introduction to Stochastic Processes in Biostatistics
W. R. Buckland,Chin Long Chiang +1 more
Journal ArticleDOI
Multinational comparative clinical evaluation of two long-acting injectable contraceptive steroids: Norethisterone oenanthate and medroxyprogesterone acetate
Giuseppe Benagiano,Egon Diczfalusy,P. Diethelm,Joseph W. Goldzieher,Ronald H. Gray,R. Apelo,N. Bergstein,J.C. de Souza,P. K. Devi,E. Kesseru,Suporn Koetsawang,O.A. Ojo,A.N. Gupta,A. Pretnar,H.K. Toppozada +14 more
TL;DR: With both treatments there were large individual variations and the bleeding pattern was totally unpredictable, and there was, with both treatments, a slight increase in body weight and a decrease in blood pressure.
Journal ArticleDOI
An analysis of the influences of maternal age, gestational age, contraceptive method, and the mode of primary treatment of patients with hydatidiform moles on the incidence of subsequent chemotherapy.
M. Stone,Kenneth D. Bagshawe +1 more
TL;DR: The need for chemotherapy for trophoblastic tumour after evacuation of a hydatidiform mole was found to be two‐ to three‐fold greater in patients who had undergone a medical induction, hysterectomy or hysterotomy compared with those whose hyd atidiform moles had been evacuated by vacuum or surgical curettage, or who had aborted spontaneously.
Journal Article
Oral contraceptives and postmolar trophoblastic disease.
TL;DR: Oral contraceptives do not appear to increase the risk of postmolar trophoblastic tumors and therefore may be safely prescribed after molar evacuation during the entire interval of gonadotropin monitoring.